首页|期刊导航|中华医学杂志（英文版）|Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization:a prospective cohort study

Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization:a prospective cohort study

He Zhao Jiaywei Tsauo Xiaowu Zhang Huaiyuan Ma Ningna Weng Zhengqiang Yang Xiao Li

中华医学杂志（英文版）2022，Vol.135Issue(17)：2043-2048,6.

中华医学杂志（英文版）2022，Vol.135Issue(17)：2043-2048,6.DOI:10.1097/CM9.0000000000002034

Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization:a prospective cohort study

He Zhao ¹Jiaywei Tsauo ²Xiaowu Zhang ¹Huaiyuan Ma ²Ningna Weng ²Zhengqiang Yang ²Xiao Li¹

作者信息

1. Department of Interventional Therapy,National Cancer Center/NationallClinical Research Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College,Beijing 100021,China
2. Department of Gastroenterology,West China Hospital,Sichuan University,Chengdu,Sichuan 610041,China
折叠

摘要

关键词

Hepatocellular carcinoma/Hepatopulmonary syndrome/Chemoembolization/Therapeutic/Prognosis/Prevalence

Key words

Hepatocellular carcinoma/Hepatopulmonary syndrome/Chemoembolization/Therapeutic/Prognosis/Prevalence

引用本文复制引用

He Zhao,Jiaywei Tsauo,Xiaowu Zhang,Huaiyuan Ma,Ningna Weng,Zhengqiang Yang,Xiao Li..Prevalence and prognostic impact of hepatopulmonary syndrome in patients with unresectable hepatocellular carcinoma undergoing transarterial chemoembolization:a prospective cohort study[J].中华医学杂志（英文版）,2022,135(17):2043-2048,6.

基金项目

This work was supported by the National Natural Science Fund of China(No.82001937)and the CAMS Initiative for Innovative Medicine(No.2021-I2M-1-015). （No.82001937）

中华医学杂志（英文版）

OACSCDCSTPCDMEDLINESCI

ISSN：0366-6999

访问量0

下载量0

段落导航